BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6278580)

  • 1. Cloning of functional human T lymphocytes by limiting dilution: impact of filler cells and interleukin 2 sources on cloning efficiencies.
    Kahle P; Wernet P; Rehbein A; Kumbier I; Pawelec G
    Scand J Immunol; 1981 Nov; 14(5):493-502. PubMed ID: 6278580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses in Hodgkin's disease: frequency distribution of IL-2 producing cells and quantitation of IL-2 produced per cell.
    Rajaram N; Damle RN; Advani SH; Gangal SG
    Indian J Biochem Biophys; 1994 Aug; 31(4):221-5. PubMed ID: 8002002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term maintenance of "cloned" human PLT cells in TCGF with LCL cells as a feeder layer.
    Hank JA; Inouye H; Guy LA; Alter BJ; Bach FH
    J Supramol Struct; 1980; 13(4):525-32. PubMed ID: 6971962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive interleukin 2 production by the JURKAT human leukemic T cell line.
    Pawelec G; Borowitz A; Krammer PH; Wernet P
    Eur J Immunol; 1982 May; 12(5):387-92. PubMed ID: 6980126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative cloning efficiencies and long-term propagation capacity for T cell clones of highly purified natural interleukin 2 compared to recombinant interleukin 2 in man.
    Pawelec G; Schwuléra U; Blaurock M; Busch FW; Rehbein A; Balko I; Wernet P
    Immunobiology; 1987 Jan; 174(1):67-75. PubMed ID: 2952583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.
    Moreau JF; Bonneville M; Peyrat MA; Godard A; Jacques Y; Desgranges C; Soulillou JP
    J Clin Invest; 1986 Oct; 78(4):874-9. PubMed ID: 3020092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
    Honda S; Takasaki T; Okuno K; Yasutomi M; Kurane I
    Acta Virol; 1998 Nov; 42(5):307-13. PubMed ID: 10358731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
    Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of single T cells and single thymocytes in a high cloning efficiency filler-cell free microculture system.
    Chen WF; Ewing T; Scollay R; Shortman K
    Thymus; 1988; 12(1):51-68. PubMed ID: 2977453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations.
    Meuer SC; Cooper DA; Hodgdon JC; Hussey RE; Morimoto C; Schlossman SF; Reinherz EL
    J Immunol; 1983 Sep; 131(3):1167-72. PubMed ID: 6309959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
    Mori T; Koishi T; Fujii G; Ohsawa N
    Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.
    Tiebout RF; Sauerwein RW; van der Meer WG; van Boxtel-Oosterhof F; Zeijlemaker WP
    Immunology; 1987 Feb; 60(2):187-93. PubMed ID: 3028938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of T cell colonies from T depleted human lymphocyte populations: analysis by limiting dilution.
    Lederman HM; Lee JW; Gelfand EW
    Clin Exp Immunol; 1985 Feb; 59(2):482-90. PubMed ID: 3872192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IL-2 and IL-4 in T lymphocytes transformed by herpesvirus saimiri.
    Chou CS; Medveczky MM; Geck P; Vercelli D; Medveczky PG
    Virology; 1995 Apr; 208(2):418-26. PubMed ID: 7747414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive production of interleukin 2 activity by a T cell hybridoma.
    Stull D; Gillis S
    J Immunol; 1981 May; 126(5):1680-3. PubMed ID: 6971310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cultivation of normal and neoplastic human T lymphocytes.
    Markham PD; Salahuddin SZ; Gallo RC
    Clin Haematol; 1984 Jun; 13(2):423-46. PubMed ID: 6088144
    [No Abstract]   [Full Text] [Related]  

  • 20. Cloning of human lymphocytes using limiting dilution.
    Morley AA; Trainor KJ; Seshadri RS
    Exp Hematol; 1983 May; 11(5):418-24. PubMed ID: 6602062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.